Spatial Proteomics in Cancer Risk Predictions

0

1. AI-enabled spatial proteomics enhances risk assessment for Barrett's esophagus.

2. 15 percent of low-risk patients were reclassified at higher risk.

3. Test uses existing biopsy samples, adding to efficiency.

4. Improves patient outcomes with risk-aligned care.

5. Supports informed decision-making for surveillance and treatment.

6. Potential impact on lowering esophageal cancer incidence.

7. Integration into current practices is seamless.